This study found significant increases in the first year, which eventually decreased in following years, regarding sickness absence and disability pensions days after a 2010 breast cancer diagnosis.
PARP inhibitors take center stage at the Society of Gynecologic Oncology’s 25th Annual Winter Meeting
This study suggested that PV prevalence among postmenopausal women may be high enough to warrant testing even in the absence of early diagnosis age or family history.
ONCOLOGY recently sat down with Kenneth C. Anderson, MD, to discuss the current trends in multiple myeloma treatment, and the explosion of novel therapies that are paving the way to better and more durable outcomes and allowing patients to live longer and more meaningful lives.
Although accumulating data continue to show immunotherapy as a major step forward in the treatment of patients with non–small cell lung cancer (NSCLC), questions regarding optimal sequencing and treatment duration still remain. At the 17th Annual Winter Lung Cancer Conference®, hosted by Physicians’ Education Resource®, LLC, multiple presentations looked for answers to address these issues.
The case of a 64-year-old white woman with hepatitis C virus infection-related well-compensated cirrhosis with hepatocellular carcinoma recuurence.
Copper intrauterine device users were found to have a lower risk of high-grade cervical neoplasms compared with levonorgestrel-releasing intrauterine system users.
Pneumocystis jirovecii Pneumonia in Patients With Metastatic Prostate Cancer on Corticosteroids for Malignant Spinal Cord Compression: Two Case Reports and a Guideline Review
Two case reports and a review of PCP in patients with solid tumors.
Although the impact of COVID-19 on trials will vary based on many factors, the FDA outlined considerations to ensure the safety of trial participants, maintain compliance with good clinical practice, and minimize the risks to trial integrity.
In this study, researchers found associations between global cognitive impairment in patients with hematologic malignancies treated with blood or marrow transplantation and genetic mechanisms that influence DNA repair, BBB, and telomere homeostasis.
Given the findings of the current study, clinicians and health services should target gender nonconforming survivor’s depression and health behaviors in order to improve survival and should also focus on the complex comorbidities of transgender men and transgender women.
These findings indicate that bone mineral density screening and pharmacologic intervention should be strongly considered for these high-risk women.
The Miami Cancer Institute is one of the leading organizations in diversity amongst its clinical trials, and chief research officer Scott Lipkin, DPM, CIP, spoke on the present and future of diversity within the organization.
This study assessed whether the accumulative, static, or dynamic method was best suited for determining the familial risk of breast cancer.
The peer-reviewed article provides insights and advice on how to continue providing proper cancer care during the novel coronavirus pandemic.